Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Insiders
100 transactions · 60 open-market buys · 7 open-market sells| Filed | Insider | Role | Transaction | Shares | Price (filed) | Value | Form |
|---|---|---|---|---|---|---|---|
| 13 Oct 2026 | Jeffrey Yu | Chief Medical Officer | open market purchase · 9 Oct 2026 | 45,126 | $5.54 | $249.99K | 4 |
| 13 Oct 2026 | Thomas Kosasa | Director | open market purchase · 7 Oct 2026 | 129,758 | $5.78 | $750.00K | 4 |
| 9 Oct 2026 | Robert Lawrence Golden | Chief Financial Officer | grant or award · 1 Jan 2026 | 10,000 | $0 | $0 | 4 |
| 9 Oct 2026 | Aaron Green | Chief Executive Officer | grant or award · 6 Jul 2026 | 65,000 | $0 | $0 | 4 |
Source: SEC filings. Information and analytics, not investment advice.